Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Standard+of+Care%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
/vufind/Search/Results?lookfor=%22Standard+of+Care%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
Search /vufind/Search2/Results?lookfor=%22Standard+of+Care%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
PubPharm (179)
1
Lifestyle : Costs and effects of a structured lifestyle program in overweight and obese subfertile couples to prevent unnecessary treatment and improve reproductive outcome
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Target attainment of ciprofloxacin in patients admitted to a general ward: a prospective observational study : Target attainment of ciprofloxacin in patients admitted to a general ward: a prospective observational study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Lifestyle : Costs and effects of a structured lifestyle program in overweight and obese subfertile couples to prevent unnecessary treatment and improve reproductive outcome
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Target attainment of ciprofloxacin in patients admitted to a general ward: a prospective observational study : Target attainment of ciprofloxacin in patients admitted to a general ward: a prospective observational study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Open-label, Dose escalation, followed by Double-blind, Randomized, Two-dose, Parallel Group, Multi-center Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Mycosis Fungoides type CTCL (stage IB-IVB) who are Refractory or Intolerant to Targretin® (bexarotene) and one other Standard Therapy - HuMax-CD4 in Refractory Mycosis Fungoides : Open-label, Dose escalation, followed by Double-blind, Randomized, Two-dose, Parallel Group, Multi-center Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Mycosis Fungoides type CTCL (stage IB-IVB) who are Refractory or Intolerant to Targretin® (bexarotene) and one other Standard Therapy - HuMax-CD4 in Refractory Mycosis Fungoides
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Open-label, Dose escalation, followed by Double-blind, Randomized, Two-dose, Parallel Group, Multi-center Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Mycosis Fungoides type CTCL (stage IB-IVB) who are Refractory or Intolerant to Targretin® (bexarotene) and one other Standard Therapy - HuMax-CD4 in Refractory Mycosis Fungoides : Open-label, Dose escalation, followed by Double-blind, Randomized, Two-dose, Parallel Group, Multi-center Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Mycosis Fungoides type CTCL (stage IB-IVB) who are Refractory or Intolerant to Targretin® (bexarotene) and one other Standard Therapy - HuMax-CD4 in Refractory Mycosis Fungoides
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Phase 3 trial of first line etoposide/platinum with or without pembrolizumab in ES-SCLC (KEYNOTE-604) : A Phase III Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab (MK 3475/SCH900475) in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subjects with Extensive Stage Small Cell Lung Cancer (KEYNOTE-604) - Phase 3 trial of first line etoposide/platinum with or without pembrolizumab in ES-SCLC(KEYNOTE-604)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Phase 3 trial of first line etoposide/platinum with or without pembrolizumab in ES-SCLC (KEYNOTE-604) : A Phase III Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab (MK 3475/SCH900475) in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subjects with Extensive Stage Small Cell Lung Cancer (KEYNOTE-604) - Phase 3 trial of first line etoposide/platinum with or without pembrolizumab in ES-SCLC(KEYNOTE-604)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies : A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies : A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
179
Aufsätze
179
E-Artikel
179
E-Ressourcen
Zeitschriftentitel
178
WHO International Clinical Trials Registry Plat...
1
ClinicalTrials.gov
Thema
179
610
Recruitment Status: Not yet recruiting
177
Study Type: Interventional
60
Phase: Phase 3
40
Phase: Phase 2
25
Phase: Phase 4
8
Medical Condition: Adjunctive therapy to standa...
8
Medical Condition: HER2 negative hormone recept...
8
Medical Condition: HER2 negative hormone recept...
8
Medical Condition: Subjects with a Urea Cycle D...
8
Medical Condition: The main purpose of this tri...
6
Medical Condition: Adjunctive therapy to standa...
6
Medical Condition: Adjuvant treatment for women...
6
Medical Condition: First-line treatment of exte...
6
Medical Condition: Long-term safety data in chi...
6
Medical Condition: Patients with type 2 diabete...
6
Medical Condition: The study objective is to ev...
4
Medical Condition: Adjunctive therapy to standa...
4
Medical Condition: First-line treatment of exte...
4
Medical Condition: HER2 negative hormone recept...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
69
2020-
110
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
175
Englisch
2
Spanisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...